{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:07:42Z","timestamp":1773486462699,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1015,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F0311-3"],"award-info":[{"award-number":["CMRPG8F0311-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F0311-3"],"award-info":[{"award-number":["CMRPG8F0311-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F0311-3"],"award-info":[{"award-number":["CMRPG8F0311-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F0311-3"],"award-info":[{"award-number":["CMRPG8F0311-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F0311-3"],"award-info":[{"award-number":["CMRPG8F0311-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F0311-3"],"award-info":[{"award-number":["CMRPG8F0311-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F0311-3"],"award-info":[{"award-number":["CMRPG8F0311-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41374-019-0356-0","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T13:02:51Z","timestamp":1576760571000},"page":"606-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response"],"prefix":"10.1016","volume":"100","author":[{"given":"Hui-Ching","family":"Chuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Lin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ming","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiin-Haur","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-019-0356-0_bib1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/13543784.2017.1380625","article-title":"Investigational drugs in phase II clinical trials for the treatment of neuroblastoma","volume":"26","author":"Amoroso","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1038\/s41374-019-0356-0_bib2","doi-asserted-by":"crossref","first-page":"7394268","DOI":"10.1155\/2018\/7394268","article-title":"Neuroblastoma origin and therapeutic targets for immunotherapy.","volume":"2018","author":"Kholodenko","year":"2018","journal-title":"J Immunol Res."},{"key":"10.1038\/s41374-019-0356-0_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/pbc.25501","article-title":"SIOP-PODC adapted risk stratification and treatment guidelines: recommendations for neuroblastoma in low- and middle-income settings","volume":"62","author":"Parikh","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1038\/s41374-019-0356-0_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jjco\/hyx176","article-title":"Neuroblastoma","volume":"48","author":"Nakagawara","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1038\/s41374-019-0356-0_bib5","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.4161\/cbt.215","article-title":"Retinoid targets in cancer therapy and chemoprevention","volume":"2","author":"Dragnev","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/s41374-019-0356-0_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2007.13.8925","article-title":"Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study","volume":"27","author":"Matthay","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41374-019-0356-0_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathol-011110-130303","article-title":"Retinoids, retinoic acid receptors, and cancer","volume":"6","author":"Tang","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1038\/s41374-019-0356-0_bib8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/carcin\/21.7.1271","article-title":"Retinoids in chemoprevention and differentiation therapy","volume":"21","author":"Hansen","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1038\/s41374-019-0356-0_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fasebj.10.9.8801164","article-title":"Retinoids in cancer chemoprevention","volume":"10","author":"Lotan","year":"1996","journal-title":"FASEB J"},{"key":"10.1038\/s41374-019-0356-0_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/bbrc.1996.1804","article-title":"Retinoic acid receptors beta and gamma distinguish retinoid signals for growth inhibition and neuritogenesis in human neuroblastoma cells","volume":"229","author":"Cheung","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/s41374-019-0356-0_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","article-title":"TLR3: interferon induction by double-stranded RNA including poly(I:C)","volume":"60","author":"Matsumoto","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1038\/s41374-019-0356-0_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2014.09.010","article-title":"Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs","volume":"146","author":"Ammi","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1038\/s41374-019-0356-0_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10495-011-0686-x","article-title":"Preferential involvement of mitochondria in toll-like receptor 3 agonist-induced neuroblastoma cell apoptosis, but not in inhibition of cell growth","volume":"17","author":"Chuang","year":"2012","journal-title":"Apoptosis"},{"key":"10.1038\/s41374-019-0356-0_bib14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ijc.20693","article-title":"GRP78 expression correlates with histologic differentiation and favorable prognosis in neuroblastic tumors","volume":"113","author":"Hsu","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1038\/s41374-019-0356-0_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1423-0127-18-65","article-title":"Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells","volume":"18","author":"Chuang","year":"2011","journal-title":"J Biomed Sci"},{"key":"10.1038\/s41374-019-0356-0_bib16","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1073\/pnas.1304610110","article-title":"Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARbeta and tumor regression","volume":"110","author":"Galli","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41374-019-0356-0_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.5","article-title":"Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells","volume":"4","author":"Bernardo","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1038\/s41374-019-0356-0_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/14740338.3.2.119","article-title":"Safety and side effects of the acne drug, oral isotretinoin","volume":"3","author":"Charakida","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1038\/s41374-019-0356-0_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sder.2008.07.002","article-title":"Preventing and managing the side effects of isotretinoin","volume":"27","author":"Brelsford","year":"2008","journal-title":"Semin Cutan Med Surg"},{"key":"10.1038\/s41374-019-0356-0_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/pbc.21768","article-title":"Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma","volume":"52","author":"Marabelle","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1038\/s41374-019-0356-0_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5306\/wjco.v6.i6.212","article-title":"Combination therapies improve the anticancer activities of retinoids in neuroblastoma","volume":"6","author":"Cheung","year":"2015","journal-title":"World J Clin Oncol"},{"key":"10.1038\/s41374-019-0356-0_bib22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.biocel.2007.02.010","article-title":"Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor","volume":"39","author":"Alvarez","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1038\/s41374-019-0356-0_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Cheung","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41374-019-0356-0_bib24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-12-3175","article-title":"Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment","volume":"19","author":"Connolly","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41374-019-0356-0_bib25","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1200\/JCO.2009.26.6452","article-title":"Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer","volume":"28","author":"Arrieta","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41374-019-0356-0_bib26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","article-title":"Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma","volume":"363","author":"Yu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/s41374-019-0356-0_bib27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/313404a0","article-title":"Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma","volume":"313","author":"Thiele","year":"1985","journal-title":"Nature"},{"key":"10.1038\/s41374-019-0356-0_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.redox.2015.11.012","article-title":"Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid","volume":"7","author":"Silvis","year":"2016","journal-title":"Redox Biol"},{"key":"10.1038\/s41374-019-0356-0_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbrc.2012.06.125","article-title":"PI3K\/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation","volume":"424","author":"Qiao","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/s41374-019-0356-0_bib30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1194\/jlr.R030833","article-title":"Vitamin A and retinoid signaling: genomic and nongenomic effects","volume":"54","author":"Al Tanoury","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1038\/s41374-019-0356-0_bib31","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0022-3468(98)90281-0","article-title":"The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression","volume":"33","author":"Zaizen","year":"1998","journal-title":"J Pediatr Surg"},{"key":"10.1038\/s41374-019-0356-0_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0008-8749(84)90136-9","article-title":"Immunological aspects of retinoids in humans. I. Analysis of retinoic acid enhancement of thymocyte responses to PHA","volume":"87","author":"Sidell","year":"1984","journal-title":"Cell Immunol"},{"key":"10.1038\/s41374-019-0356-0_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0008-8749(84)90170-9","article-title":"Immunological aspects of retinoids in humans. II. Retinoic acid enhances induction of hemolytic plaque-forming cells","volume":"88","author":"Sidell","year":"1984","journal-title":"Cell Immunol"},{"key":"10.1038\/s41374-019-0356-0_bib34","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1158\/1078-0432.CCR-17-1866","article-title":"Therapeutic immune modulation against solid cancers with intratumoral poly-ICLC: a pilot trial.","volume":"24","author":"Kyi","year":"2018","journal-title":"Clin Cancer Res."},{"key":"10.1038\/s41374-019-0356-0_bib35","first-page":"39","article-title":"Human neuroblastoma cells and 13-cis-retinoic acid","volume":"3","author":"Helson","year":"1985","journal-title":"J Neurooncol"},{"key":"10.1038\/s41374-019-0356-0_bib36","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1158\/1078-0432.CCR-13-1486","article-title":"PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma","volume":"20","author":"Shah","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41374-019-0356-0_bib37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1054\/bjoc.2000.1425","article-title":"A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy","volume":"83","author":"Kohler","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1038\/s41374-019-0356-0_bib38","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group","volume":"341","author":"Matthay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/s41374-019-0356-0_bib39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.bjc.6603554","article-title":"Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma\u2014a study of the United Kingdom Children's Cancer Study Group","volume":"96","author":"Veal","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1038\/s41374-019-0356-0_bib40","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1016\/j.jmb.2013.10.007","article-title":"Mechanisms of MAVS regulation at the mitochondrial membrane","volume":"425","author":"Jacobs","year":"2013","journal-title":"J Mol Biol"},{"key":"10.1038\/s41374-019-0356-0_bib41","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/jcmm.12256","article-title":"Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor beta","volume":"18","author":"Flamini","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1038\/s41374-019-0356-0_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-4827(83)90184-2","article-title":"Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines","volume":"148","author":"Sidell","year":"1983","journal-title":"Exp Cell Res"},{"key":"10.1038\/s41374-019-0356-0_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/15384101.2015.1125243","article-title":"Telomere maintenance is pivotal for high-risk neuroblastoma","volume":"15","author":"Hertwig","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1038\/s41374-019-0356-0_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.humpath.2018.07.032","article-title":"ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors","volume":"82","author":"Chou","year":"2018","journal-title":"Hum Pathol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0356-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0356-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722012491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722012491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0356-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:37:54Z","timestamp":1758397074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722012491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0023683722012491"],"URL":"https:\/\/doi.org\/10.1038\/s41374-019-0356-0","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-019-0356-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}